首页> 外文期刊>Journal of biomedical materials research, Part A >Exploring the in vitro in vitro and in vivo in vivo compatibility of PLA, PLA/GNP and PLA/CNT‐COOH biodegradable nanocomposites: Prospects for tendon and ligament applications
【24h】

Exploring the in vitro in vitro and in vivo in vivo compatibility of PLA, PLA/GNP and PLA/CNT‐COOH biodegradable nanocomposites: Prospects for tendon and ligament applications

机译:PLA,PLA / GNP和PLA / CNT-COOH可生物降解纳米复合材料的体内体外和体内体内体内和体内探索体外的体外和体内体内的体外相容性:肌腱和韧带应用的前景

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Anterior cruciate ligament (ACL) reconstructive surgeries are the most frequent orthopedic procedures in the knee. Currently, existing strategies fail in completely restoring tissue functionality and have a high failure rate associated, presenting a compelling argument towards the development of novel materials envisioning ACL reinforcement. Tendons and ligaments, in general, have a strong demand in terms of biomechanical features of developed constructs. We have previously developed polylactic acid (PLA)‐based biodegradable films reinforced either with graphene nanoplatelets (PLA/GNP) or with carboxyl‐functionalized carbon nanotubes (PLA/CNT‐COOH). In the present study, we comparatively assessed the biological performance of PLA, PLA/GNP, and PLA/CNT‐COOH by seeding human dermal fibroblasts (HFF‐1) and studying cell viability and proliferation. In vivo tests were also performed by subcutaneous implantation in 6‐week‐old C57Bl/6 mice. Results showed that all formulations studied herein did not elicit cytotoxic responses in seeded HFF‐1, supporting cell proliferation up to 3 days in culture. Moreover, animal studies indicated no physiological signs of severe inflammatory response after 1 and 2 weeks after implantation. Taken together, our results present a preliminary assessment on the compatibility of PLA reinforced with GNP and CNT‐COOH nanofillers, highlighting the potential use of these carbon‐based nanofillers for the fabrication of reinforced synthetic polymer‐based structures for ACL reinforcement. ? 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2182–2190, 2017.
机译:摘要前令韧带(ACL)重建手术是膝关节中最常见的骨科手术。目前,现有策略在完全恢复的组织功能中失败,并具有高的故障率,呈现出对新型材料的开发设想ACL加固的令人信服的论点。一般而言,肌腱和韧带在发育构建体的生物力学特征方面具有很强的需求。我们先前已经开发出具有基于石墨烯纳米片(PLA / GNP)或用羧基官能化碳纳米管(PLA / CNT-COOH)增强的聚致酸(PLA)的可生物降解薄膜。在本研究中,我们通过播种人的皮肤成纤维细胞(HFF-1)和研究细胞活力和增殖来相比评估PLA,PLA / GNP和PLA / CNT-COOH的生物学性能。在体内测试中也通过皮下植入植入6周龄C57BL / 6小鼠进行。结果表明,本文研究的所有制剂在种子HFF-1中没有引发细胞毒性反应,在培养中支持3天的细胞增殖。此外,动物研究表明植入后1和2周后没有严重炎症反应的生理迹象。我们的结果表明了对用GNP和CNT-COOH纳米氧化物增强的PLA的相容性提高了初步评估,突出了这些碳基纳米填料的潜在用途,用于制造加强合成聚合物的ACL增强件的结构。还2017年Wiley期刊,Inc。J生物保罗第A:105A:2182-2190,2017。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号